Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Cancer screening

Cancer screening company Burning Rock Biotech announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National Medical Products Administration (NMPA).

FAST NEWS: Burning Rock’s cancer test gets breakthrough designation

The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
October 17, 2023

FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business

The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
March 30, 2022

Recent Articles

Cancer screening company Burning Rock Biotech announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National Medical Products Administration (NMPA).
October 17, 2023

FAST NEWS: Burning Rock’s cancer test gets breakthrough designation

March 30, 2022

FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business

RELATED ARTICLES

  1. December 4, 2024
    BRIEF: Burning Rock returns to revenue growth as loss narrows
    BNR.US
  2. March 25, 2025
    Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  3. March 27, 2025
    CARsgen seeks cell therapy breakthrough but stays in the red for now
    2171.HK
  4. December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  5. February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
  6. March 20, 2025
    A blockbuster cancer drug? TYK’s claims go under the microscope
    2410.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.